Barry Canton Ginkgo Bioworks Holdings, Inc. (DNA) insider trading activity

Barry Canton is > 10% Shareholder of Ginkgo Bioworks Holdings, Inc.. Currently has a direct ownership of 12.4 Million shares of DNA, which is worth approximately $77.1 Million. The most recent transaction as insider was on Nov 08, 2022, when has been sold 193,616 shares (Class A Common Stock) at a price of $2.46 per share, resulting in proceeds of $476,295. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.4M

0% 3M change

4.09% 12M change

Total Value Held $77.1 Million

Barry Canton Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 08 2022	SELL Open market or private sale	$476,295 $2.46 p/Share	193,616 Reduced 0.87%	22,175,747 Class A Common Stock
Nov 07 2022	SELL Open market or private sale	$498,057 $2.42 p/Share	205,809 Reduced 0.91%	22,369,363 Class A Common Stock
Nov 04 2022	SELL Open market or private sale	$514,314 $2.51 p/Share	204,906 Reduced 0.9%	22,575,172 Class A Common Stock
Nov 01 2022	SELL Open market or private sale	$543,773 $2.77 p/Share	196,308 Reduced 0.85%	22,780,078 Class A Common Stock
Oct 31 2022	SELL Open market or private sale	$534,327 $2.7 p/Share	197,899 Reduced 0.85%	22,976,386 Class A Common Stock
Oct 28 2022	SELL Open market or private sale	$524,177 $2.63 p/Share	199,307 Reduced 0.85%	23,174,285 Class A Common Stock
Oct 27 2022	SELL Open market or private sale	$554,135 $2.71 p/Share	204,478 Reduced 0.87%	23,373,592 Class A Common Stock
Oct 26 2022	SELL Open market or private sale	$548,500 $2.9 p/Share	189,138 Reduced 0.8%	23,578,070 Class A Common Stock
Oct 25 2022	SELL Open market or private sale	$494,844 $2.64 p/Share	187,441 Reduced 0.78%	23,767,208 Class A Common Stock
Oct 24 2022	SELL Open market or private sale	$512,127 $2.48 p/Share	206,503 Reduced 0.85%	23,954,649 Class A Common Stock
Oct 21 2022	SELL Open market or private sale	$491,345 $2.44 p/Share	201,371 Reduced 0.83%	24,161,152 Class A Common Stock
Oct 20 2022	SELL Open market or private sale	$485,901 $2.47 p/Share	196,721 Reduced 0.8%	24,362,523 Class A Common Stock
Oct 19 2022	SELL Open market or private sale	$529,572 $2.5 p/Share	211,829 Reduced 0.86%	24,559,244 Class A Common Stock
Oct 18 2022	SELL Open market or private sale	$522,855 $2.64 p/Share	198,051 Reduced 0.79%	24,771,073 Class A Common Stock
Oct 17 2022	SELL Open market or private sale	$515,637 $2.64 p/Share	195,317 Reduced 0.78%	24,969,124 Class A Common Stock
Oct 14 2022	SELL Open market or private sale	$565,784 $2.62 p/Share	215,948 Reduced 0.85%	25,164,441 Class A Common Stock
Oct 13 2022	SELL Open market or private sale	$567,923 $2.74 p/Share	207,271 Reduced 0.81%	25,380,389 Class A Common Stock
Oct 12 2022	SELL Open market or private sale	$593,093 $2.81 p/Share	211,065 Reduced 0.82%	25,587,660 Class A Common Stock
Oct 11 2022	SELL Open market or private sale	$575,248 $2.87 p/Share	200,435 Reduced 0.77%	25,798,725 Class A Common Stock
Oct 10 2022	SELL Open market or private sale	$615,096 $2.88 p/Share	213,575 Reduced 0.81%	25,999,160 Class A Common Stock
Oct 03 2022	SELL Open market or private sale	$1,070,385 $3.12 p/Share	343,072 Reduced 1.29%	26,212,735 Class A Common Stock
Sep 30 2022	BUY Exercise of conversion of derivative security	-	773,453 Added 50.0%	773,453 Class A Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	-	25,782,354 Added 49.26%	26,555,807 Class A Common Stock

Barry Canton

> 10% Shareholder

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DNA shares.

Notify only if

Value

Insider Trading

Get notified when an Ginkgo Bioworks Holdings, Inc. insider buys or sells DNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Ginkgo Bioworks Holdings, Inc.

Track Activities on DNA

Account